Showing 8,261 - 8,280 results of 18,449 for search 'significant ((((nn decrease) OR (((a decrease) OR (greater decrease))))) OR (mean decrease))', query time: 0.73s Refine Results
  1. 8261

    Antibody description. by Qi He (384033)

    Published 2025
    “…<div><p>Background</p><p>Chronic stress has emerged as a prevalent facet of contemporary existence, significantly jeopardizing overall bodily health. …”
  2. 8262

    Raw data of this article. by Qi He (384033)

    Published 2025
    “…<div><p>Background</p><p>Chronic stress has emerged as a prevalent facet of contemporary existence, significantly jeopardizing overall bodily health. …”
  3. 8263

    Table 1_Efgartigimod combined with steroids as a fast-acting therapy for anti-SRP immune-mediated necrotizing myopathy.doc by Qiqi Peng (6560057)

    Published 2025
    “…</p>Results<p>Following one cycle of efgartigimod treatment (administered at a dosage of 10 mg/kg, once a week for a total of 4 injections in one period) in these three patients, CK values decreased by 79.30, 95.80, and 93.62%, respectively. …”
  4. 8264

    Supplementary file 1_Case Report: A case of reversible tracheal diameter Mounier-Kuhn syndrome and literature review.docx by Lu-xia Kong (21191087)

    Published 2025
    “…We encountered an 81-year-old male MKS patient whose diagnosis was delayed, and subsequently experienced a significant decrease in tracheal diameter post-diagnosis, marking the first documented case of reversible tracheal diameter in MKS patients. …”
  5. 8265

    Gene expression of neurotransmitter pathways at 6 dp. by Morgan Barnes (7876373)

    Published 2025
    “…In the 24 hpf dnVDRa induced group we see a significant decrease in glyt1 expression (p < 0.05) and an increase in glyt2 expression (p < 0.05) and in slc32a1 expression (p < 0.01). …”
  6. 8266

    Quantification of faecal glucocorticoid metabolites as a measure of stress in the rock hyrax (Procavia capensis) living in an urban green space by Scheun, Juan (8229483)

    Published 2025
    “…Animal FID did not differ significantly between seasons but they did differ significantly between sections, and decreased in accordance with fGCM concentrations. …”
  7. 8267

    PCAIs inhibit NCI-H23 cell line viability. by Matthew D. Gregory (19929096)

    Published 2024
    “…However, CRAF/RAF1 phosphorylation decreased by 40%, suggesting significant changes in the KRAS/MAPK signaling patterns. …”
  8. 8268

    PCAIs disrupt actin filaments in NCI-H23 cells. by Matthew D. Gregory (19929096)

    Published 2024
    “…However, CRAF/RAF1 phosphorylation decreased by 40%, suggesting significant changes in the KRAS/MAPK signaling patterns. …”
  9. 8269

    PCAIs suppress 3D NCI-H23 cell invasion. by Matthew D. Gregory (19929096)

    Published 2024
    “…However, CRAF/RAF1 phosphorylation decreased by 40%, suggesting significant changes in the KRAS/MAPK signaling patterns. …”
  10. 8270

    PCAIs suppress NCI-H23 cancer cell migration. by Matthew D. Gregory (19929096)

    Published 2024
    “…However, CRAF/RAF1 phosphorylation decreased by 40%, suggesting significant changes in the KRAS/MAPK signaling patterns. …”
  11. 8271

    PCAIs induce apoptosis in NCI-H23 cells. by Matthew D. Gregory (19929096)

    Published 2024
    “…However, CRAF/RAF1 phosphorylation decreased by 40%, suggesting significant changes in the KRAS/MAPK signaling patterns. …”
  12. 8272

    Visual motor response assay at 28 dpf. by Morgan Barnes (7876373)

    Published 2025
    “…(E-H) VMR parameters in dnVDRa induced zebrafish at 48 hpf. There is a significant decrease in distance moved in the dark period (p < 0.05), a significant decrease in velocity in the dark (p < 0.05) and light (p < 0.01) periods, a significant decrease in activity state in the dark period (p < 0.001) and light period (p < 0.01) and a significant decrease in distance to point in the dark period (p < 0.05) and light period (p < 0.05) in the 48 + fish. …”
  13. 8273

    Table1_Safety evaluation of medroxyprogesterone acetate: a pharmacovigilance analysis using FDA adverse event reporting system data.DOCX by Luyang Su (20411552)

    Published 2025
    “…Unforeseen significant AEs such as unintended pregnancy (n = 623; ROR, 6.65; ROR025, 6.1; χ<sup>2</sup>, 2,482.38; PRR, 6.41; EBGM, 5.69; EBGM05, 5.29), bone pain (n = 35; ROR, 13.78; ROR025, 9.4; χ<sup>2</sup>, 311.2; PRR, 13.75; EBGM, 10.59; EBGM05, 7.69), gait disturbance (n = 34; ROR, 2.82; ROR025, 1.99; χ<sup>2</sup>, 37.31; PRR, 2.88; EBGM, 2.7; EBGM05, 2.02), dental caries (n = 15; ROR, 23.16; ROR025, 12.32; χ<sup>2</sup>, 204.26; PRR, 23.14; EBGM, 15.23; EBGM05, 8.98), decrease in blood pressure (n = 15; ROR, 3.88; ROR025, 2.29; χ<sup>2</sup>, 29.35; PRR, 3.88; EBGM, 3.63; EBGM05, 2.33), and osteonecrosis (n = 9; ROR, 23.44; ROR025, 10.36; χ<sup>2</sup>, 123.67; PRR, 23.43; EBGM, 15.35; EBGM05, 7.75) were identified as AEs that were not previously outlined in the prescribing information of the medication.…”
  14. 8274

    Table1_Safety evaluation of medroxyprogesterone acetate: a pharmacovigilance analysis using FDA adverse event reporting system data.DOCX by Luyang Su (20411552)

    Published 2024
    “…Unforeseen significant AEs such as unintended pregnancy (n = 623; ROR, 6.65; ROR025, 6.1; χ<sup>2</sup>, 2,482.38; PRR, 6.41; EBGM, 5.69; EBGM05, 5.29), bone pain (n = 35; ROR, 13.78; ROR025, 9.4; χ<sup>2</sup>, 311.2; PRR, 13.75; EBGM, 10.59; EBGM05, 7.69), gait disturbance (n = 34; ROR, 2.82; ROR025, 1.99; χ<sup>2</sup>, 37.31; PRR, 2.88; EBGM, 2.7; EBGM05, 2.02), dental caries (n = 15; ROR, 23.16; ROR025, 12.32; χ<sup>2</sup>, 204.26; PRR, 23.14; EBGM, 15.23; EBGM05, 8.98), decrease in blood pressure (n = 15; ROR, 3.88; ROR025, 2.29; χ<sup>2</sup>, 29.35; PRR, 3.88; EBGM, 3.63; EBGM05, 2.33), and osteonecrosis (n = 9; ROR, 23.44; ROR025, 10.36; χ<sup>2</sup>, 123.67; PRR, 23.43; EBGM, 15.35; EBGM05, 7.75) were identified as AEs that were not previously outlined in the prescribing information of the medication.…”
  15. 8275

    Supplementary file 1_The action of ginsenoside Rg1 in patients with carotid atherosclerosis: a controlled clinical trial.docx by Xu Fang (450501)

    Published 2025
    “…Group 3 received the same treatment as Group 2, but with Bayaspirin replaced by ginsenoside Rg1 (n = 41). This study adopted a single-blind design: by uniformly encapsulating the tablets in their original form in blind bags, the subjects took them at regular intervals and in fixed quantities There were no significant differences in baseline characteristics among the groups before treatment (P > 0.05). …”
  16. 8276

    A study of the mediating role of bedtime music in employment anxiety and sleep quality among college students DATA.xl by Xu Qiujian (19715689)

    Published 2024
    “…Specifically, β decreased from 0.583 to 0.53, and T decreased from 25.717 to 22.91 Nevertheless, employment anxiety still exhibited a substantial impact on sleep quality (β = 0.53; T = 22.91; P < 0.001).Conclusion: This study concludes that employment-related anxiety has a positive and significant effect on sleep quality. …”
  17. 8277

    Image 2_Enhanced cognitive control following neurofeedback therapy in chronic treatment-resistant PTSD among refugees: a feasibility study.tiff by Mirjana Askovic (6562304)

    Published 2025
    “…Post-treatment, clients were categorised into Responders and Non-Responders, with responders defined as those achieving a clinically significant reduction in PTSD symptoms (≥0.5-point decrease on the HTQ).…”
  18. 8278

    Image 1_Enhanced cognitive control following neurofeedback therapy in chronic treatment-resistant PTSD among refugees: a feasibility study.tiff by Mirjana Askovic (6562304)

    Published 2025
    “…Post-treatment, clients were categorised into Responders and Non-Responders, with responders defined as those achieving a clinically significant reduction in PTSD symptoms (≥0.5-point decrease on the HTQ).…”
  19. 8279

    Table 1_Enhanced cognitive control following neurofeedback therapy in chronic treatment-resistant PTSD among refugees: a feasibility study.pdf by Mirjana Askovic (6562304)

    Published 2025
    “…Post-treatment, clients were categorised into Responders and Non-Responders, with responders defined as those achieving a clinically significant reduction in PTSD symptoms (≥0.5-point decrease on the HTQ).…”
  20. 8280

    Glial 5-HT<sub>2a</sub> receptors are necessary and rate limiting for experience-dependent synaptic glomeruli pruning. by Vanessa Kay Miller (19775496)

    Published 2024
    “…The Or42a OSN innervation volume with glial <i>5-HT</i><sub><i>2A</i></sub><i>R</i> OE is very significantly decreased in comparison to the control EB condition (<i>p</i> = 4.64 × 10<sup>−10</sup>). …”